연구성과로 돌아가기
2024 연구성과별 연구자 정보 (59 / 2344)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA) | Kim, T-H. | Kim, TH | 12 | Kyungpook Natl Univ, Sch Med, Dept Urol, Daegu, South Korea | ||||||
| A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA) | Rodriguez, C. Suarez | Rodriguez, CS | 13 | Hosp Univ Vall Hebron, Vall Hebron Inst Oncol VHIO, Med Oncol, Vall Hebron Barcelona Hosp Campus, Barcelona, Spain | ||||||
| A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA) | Chang, C-H. | Chang, CH | 14 | China Med Univ & Hosp, Dept Urol, Taichung, Taiwan | ||||||
| A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA) | Chang, C-H. | Chang, CH | 14 | China Med Univ & Hosp, Sch Med, Taichung, Taiwan | ||||||
| A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA) | Roghmann, F. | Roghmann, F | 15 | Ruhr Univ Bochum, Marien Hosp, Univ Hosp, Dept Urol, Herne, Germany | ||||||
| A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA) | Ozguroglu, M. | Ozguroglu, M | 16 | Istanbul Univ Cerrahpasa, Cerrahpasa Med Sch, Dept Internal Med, Istanbul, Turkey | ||||||
| A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA) | Armstrong, J. | Armstrong, J | 17 | AstraZeneca, Stat, Cambridge, England | ||||||
| A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA) | Ho, S. | Ho, S | 18 | AstraZeneca, Oncol, Gaithersburg, MD USA | ||||||
| A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA) | Hois, S. | Hois, S | 19 | AstraZeneca, Oncol, Gaithersburg, MD USA | ||||||
| A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA) | Catto, J. | Catto, J | 20 | Univ Sheffield, Sch Med & Populat Hlth, Div Clin Med, Sheffield, S Yorkshire, England | ||||||
| A randomized phase III trial of neoadjuvant durvalumab plus chemotherapy followed by radical cystectomy and adjuvant durvalumab in muscle-invasive bladder cancer (NIAGARA) | Catto, J. | Catto, J | 20 | Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England | ||||||
| A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia | Lim, H. | Lim, H | 1 | Keimyung Univ, Dongsan Hosp, Dept Urol, Daegu, South Korea | ||||||
| A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia | Shin, T. J. | Shin, TJ | 2 | Keimyung Univ, Dongsan Hosp, Dept Urol, Daegu, South Korea | ||||||
| A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia | Ha, J. Y. | Ha, JY | 3 | Keimyung Univ, Dongsan Hosp, Dept Urol, Daegu, South Korea | KSM-0577-2024 | Ha, Ji Yong | ||||
| A randomized, active-controlled, multicenter, phase 3 clinical trial to evaluate the efficacy and safety of GV1001 in patients with benign prostatic hyperplasia | Kwon, S. Y. | Kwon, SY | 4 | Dongguk Univ, Gyeongju Hosp, Dept Urol, Gyeongju, South Korea |
페이지 이동: